| Are you making compromises in your hemophilia treatment? |
| If you’re living with hemophilia, you may be making trade-offs by compromising on bleed protection or ease of administration. |
| |
 |
| Large needles for injections and infusions |
|
|
 |
| Injecting large volume doses for better coverage |
|
 |
| Too many administration steps and supplies |
|
|
 |
| Planning activities around treatment schedule |
|
|
|
|
|
|
| even some doctors weren’t completely satisfied with current prophylaxis treatments. Are you? |
|
|
| In a survey of 62 doctors: |
| • |
40% were not completely satisfied with non-factor therapy that works like Factor 8 (Factor 8 mimetic therapy) |
| • |
53% felt the same about Factor 8 extended half-life therapy due to concerns about administration and dosing |
|
| These doctors had concerns about efficacy (how well the product treats bleeds), and side effects/safety, too.a,b |
| Reasons why physicians said they were not completely satisfied: |
 |
|
|
| Reasons why physicians said they were not completely satisfied: |
 |
|
| aThe number of HCPs who have reported being satisfied with current treatment is unknown. |
| bBased on a study of 326 patients with hemophilia A, 62 physicians were asked if they were completely satisfied with their patient's prophylactic treatment. Physicians reported reasons for dissatisfaction on behalf of 31 patients on FVIII mimetic and 55 patients on FVIII EHL prophylaxis. |
| Questions asked: “Please indicate your overall satisfaction with the current treatment in terms of how well it manages the patient’s hemophilia” and “Why are you not completely satisfied with the patient's current prophylactic treatment?” |
|
|
| Researchers continue to explore different ways to prevent bleeds |
| While non-factor therapies have improved options for people living with hemophilia A, researchers are still investigating in a few key areas, including: |
| • |
How therapies work with the clotting cascade |
| • |
How therapy is administered |
| • |
How much and how often treatments are dosed |
|
| Keeping track of your treatment experiences can help show evidence of your concerns when speaking with your doctor. Here’s a discussion guide that can help. |
|
|
|
|
|
|
|
| Stay in the know |
|
|
| Don’t miss out on the latest hemophilia updates and resources from Novo Nordisk. |
|
|
|
|
|
| Please do not respond to this email. If you would like to contact us, please click here or call 1‑877‑744‑2579. |
|
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
© 2025 Novo Nordisk All rights reserved. US25HRBD00121 September 2025 |
 |
|
|
|
